GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder

Epstein-Barr virus-associated lymphoproliferative disease (EBV-LPD) is a potentially life-threatening complication in immune-deficient patients. We have used the severe combined immune deficient (SCID) mouse engrafted with human leukocytes (hu-PBL-SCID) to evaluate the use of human cytokines in the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of clinical investigation 2001-09, Vol.108 (6), p.887-894
Hauptverfasser:	Baiocchi, R A, Ward, J S, Carrodeguas, L, Eisenbeis, C F, Peng, R, Roychowdhury, S, Vourganti, S, Sekula, T, O'Brien, M, Moeschberger, M, Caligiuri, M A
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Disease Models, Animal Epstein-Barr virus Epstein-Barr Virus Infections - immunology Epstein-Barr Virus Infections - prevention & control Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology Humans Immunity, Cellular - drug effects Interleukin-2 - administration & dosage Interleukin-2 - pharmacology Killer Cells, Natural - immunology Leukocyte Transfusion Lymphoproliferative Disorders - immunology Lymphoproliferative Disorders - prevention & control Mice Mice, SCID T-Lymphocyte Subsets - drug effects T-Lymphocyte Subsets - immunology Transplantation, Heterologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!